Results 241 to 250 of about 31,334 (301)

Optimizing the diagnosis of primary aldosteronism: The role of adrenal vein sampling and the need for high‐expertise reference centers

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 4, April 2026.
Abstract Adrenal vein sampling (AVS) is the cornerstone diagnostic procedure for subtype differentiation in primary hyperaldosteronism, guiding therapeutic decision‐making and offering the possibility of curative surgery to a subset of patients.
Aura D. Herrera‐Martínez   +15 more
wiley   +1 more source

Testosterone, cortisol, and fNIRS‐based cortical activation associated with competitive task persistence and difficulty

open access: yesJournal of Neuroendocrinology, Volume 38, Issue 4, April 2026.
Abstract Motivation for social or resource‐related rewards is regulated by areas of the brain that control executive functioning and regulate attention, including the prefrontal cortex (PFC) and temporoparietal junction (TPJ). Testosterone and cortisol are two steroid hormones that influence behaviors related to motivation in social competition and are
Kathleen V. Casto   +3 more
wiley   +1 more source

Emerging Medical Therapies for Primary Aldosteronism. [PDF]

open access: yesHypertension
Vibhatavata P, Turcu AF.
europepmc   +1 more source

Human DRG Glucocorticoid Receptor Profiling Reveals Targets for Regionally Delivered Steroid Analgesia. [PDF]

open access: yesCells
Mousa SA   +8 more
europepmc   +1 more source

Mineralocorticoid Receptor Blockers: Novel Selective Nonsteroidal Mineralocorticoid Receptor Antagonists

Current Hypertension Reports, 2020
Recently, nonsteroidal mineralocorticoid receptor (MR) antagonists (MRAs), which have been proposed to be called MR blockers (MRBs), have become available for clinical use, but their clinical role is unknown. We reviewed the clinical roles of MRAs and MRBs based on previous knowledge and as demonstrated in representative clinical trials.Steroidal MRAs,
Daisuke, Sueta   +2 more
openaire   +2 more sources

Mineralocorticoid receptor antagonists

Current Hypertension Reports, 2007
With an increasingly aging population, the need for effective treatment of cardiovascular diseases (eg, heart failure, hypertension, and ischemic heart disease) cannot be overemphasized. The vital importance of mineralocorticoid receptor antagonists for treating cardiovascular conditions has only been appreciated in the last decade. The re-emergence of
Parthasarathy, Hari Krishnan   +1 more
openaire   +3 more sources

Adipocyte Mineralocorticoid Receptor

2019
Mineralocorticoid receptor (MR) has been recently identified in adipose tissue, where its excessive activation contributes to several metabolic derangements often observed in obesity and metabolic syndrome. Recent findings support the existence of a bidirectional cross-talk between adipose tissue and adrenal glands, contributing to obesity-related ...
Infante M.   +4 more
openaire   +4 more sources

Rapid mineralocorticoid receptor trafficking

Steroids, 2014
The mineralocorticoid receptor (MR) is a ligand-dependent transcription factor that physiologically regulates water-electrolyte homeostasis and controls blood pressure. The MR can also elicit inflammatory and remodeling processes in the cardiovascular system and the kidneys, which require the presence of additional pathological factors like for example
M, Gekle   +4 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy